Changing Reimbursement Criteria on Anti-VEGF Treatment Patterns Among Wet Age-Related Macular Degeneration and Diabetic Macular Edema Patients: An Interrupted Time Series Analysis
International Journal of Health Policy and Management · 2024
DOI: 10.34172/ijhpm.8210 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Policy and Management, 2024. Verfasst von Yu-Wen Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Interrupted Time Series Analysis, Macular Edema, Diabetic Retinopathy, Angiogenesis Inhibitors. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
To evaluate the impact of reimbursement criteria change on the utilization pattern of anti-vascular endothelial growth factor (anti-VEGF) among patients with wet age-related macular degeneration (wAMD) and diabetic macular edema (DME) separately in Taiwan.
Methods
An interrupted time series analysis (ITSA) was performed using Taiwan’s National Health Insurance (NHI) database, and patients with wAMD or DME diagnosis at the first injection of anti-VEGF agents was identified from 2011 to 2019. The outcome of interest was treatment gaps between injections of anti-VEGF. This outcome was retrieved quarterly, and the study period was divided into three phases in wAMD (two criteria changed in August 2014 [intervention] and December 2016 [intervention]) and two phases in DME (three consecutive criteria changed in 2016 [intervention]). Segmented regression models adjusted for autocorrelation were used to estimate the change in level and the change in slope of the treatment gaps between each anti-VEGF injection.
Results
The treatment gaps between each anti-VEGF injection decreased from 2011 to 2019. The cancellation of the annual three needles limitation was associated with significantly shortened treatment gaps between the third and fourth needles (wAMD change in level: -228 days [95% CI -282, -173], DME change in level: -110 days [95% CI -141, -79]). The treatment gap between the fifth and sixth needles revealed a similar pattern but without significant change in DME patients. Other treatment gaps revealed considerable change in slopes in accordance with criteria changes.
Conclusion
This is the first nationwide study using ITSA to demonstrate the impact of reimbursement policy on treatment gaps between each anti-VEGF injection. After canceling the annual limitation, we found that the treatment gaps significantly decreased among wAMD and DME patients. The shortened treatment gaps might further link to better visual outcomes according to previous studies. The different impacts from criteria changes can assist future policy shaping. Future studies were warranted to explore whether such changes are associated with the benefits of visual effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, National Taiwan University, Taipei, Taiwan.
- Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
- Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taipei, Taiwan.
- Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
- Taipei Municipal Gan-Dau Hospital (Managed by Taipei Veterans General Hospital), Taipei, Taiwan.
ORCID-Profile: Yu-Wen Huang, Lin-Chieh Meng, Li-Jiuan Shen, Liang-Kung Chen, Fei-Yuan Hsiao
Zitieren
APA
Huang, Y. W., Meng, L. C., Shen, L. J., Huang, C. F., Chen, L. K., & Hsiao, F. Y. (2024). Changing Reimbursement Criteria on Anti-VEGF Treatment Patterns Among Wet Age-Related Macular Degeneration and Diabetic Macular Edema Patients: An Interrupted Time Series Analysis. International Journal of Health Policy and Management. https://doi.org/10.34172/ijhpm.8210
Vancouver
Huang YW, Meng LC, Shen LJ, Huang CF, Chen LK, Hsiao FY. Changing Reimbursement Criteria on Anti-VEGF Treatment Patterns Among Wet Age-Related Macular Degeneration and Diabetic Macular Edema Patients: An Interrupted Time Series Analysis. International Journal of Health Policy and Management. 2024. doi:10.34172/ijhpm.8210
BibTeX
@article{Huang2024,
author = {Huang, Yu-Wen and Meng, Lin-Chieh and Shen, Li-Jiuan and Huang, Chih-Fen and Chen, Liang-Kung and Hsiao, Fei-Yuan},
title = {Changing Reimbursement Criteria on Anti-VEGF Treatment Patterns Among Wet Age-Related Macular Degeneration and Diabetic Macular Edema Patients: An Interrupted Time Series Analysis},
journal = {International Journal of Health Policy and Management},
year = {2024},
doi = {10.34172/ijhpm.8210}
}
EUVIMED